Ioflupane I-123 Patent Expiration
Ioflupane I-123 was first introduced by Ge Healthcare Inc
Ioflupane I-123 Patents
Given below is the list of patents protecting Ioflupane I-123, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Datscan | US5310912 | Iodinated neuroprobe for mapping monoamine reuptake sites |
Feb 25, 2013
(Expired) | Ge Hlthcare Inc |
Ioflupane I-123's Family Patents
Explore Our Curated Drug Screens
Ioflupane I-123 Generic API Manufacturers
Only one generic application has been filed for Ioflupane I-123.
Given below is the list of companies who have filed for Ioflupane I-123 generic, along with the locations of their manufacturing plants worldwide.
1. CURIUM
Curium Us Llc has filed for 1 generic for Ioflupane I-123. Given below are the details of the strengths of this generic introduced by Curium.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5mCi/2.5ML (2mCi/ML) | solution | Prescription | INTRAVENOUS | AP | Mar 30, 2022 |
Manufacturing Plant Locations New
Curium's manufacturing plants are situated in 2 countries - Netherlands, United States. Given below are the details of these plant locations as well as the firm names of Curium as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| Netherlands |
| |||||
| United States |
| |||||